Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review Date: January 26, 2022 By: echo_wpbaycrest_admin Categories: Responsive Behaviours Read More
Posttraumatic stress disorder and risk of dementia among US veterans Date: January 21, 2022 By: echo_wpbaycrest_admin Categories: Responsive Behaviours Read More
Delayed-onset post-traumatic stress disorder symptoms in dementia Date: January 21, 2022 By: echo_wpbaycrest_admin Categories: Responsive Behaviours Read More
Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer’s Disease Date: January 20, 2022 By: echo_wpbaycrest_admin Categories: Responsive Behaviours Read More
Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel Date: January 20, 2022 By: echo_wpbaycrest_admin Categories: Responsive Behaviours Read More
Cannabinoids for the Neuropsychiatric Symptoms of Dementia- A Systematic Review and Meta-Analysis Date: January 20, 2022 By: echo_wpbaycrest_admin Categories: Responsive Behaviours Read More
Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia – State of the Art and Future Progress Date: March 29, 2021 By: echo_wpbaycrest_admin Categories: Responsive Behaviours, Screening, Assessment & Pharmacological Treatments Read More
Valproate preparations for agitation in dementia Date: March 29, 2021 By: echo_wpbaycrest_admin Categories: Responsive Behaviours, Screening, Assessment & Pharmacological Treatments Read More
Pharmacologic Management of Agitation in Patients with Dementia Date: March 29, 2021 By: echo_wpbaycrest_admin Categories: Responsive Behaviours, Screening, Assessment & Pharmacological Treatments Read More
Management of the behavioral and psychological symptoms of dementia Date: March 29, 2021 By: echo_wpbaycrest_admin Categories: Responsive Behaviours Read More
